GF
RPTP

Gabelli Funds’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Gabelli Funds’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-514,500
Closed -$4.62M – 1203
2016
Q3 		$4.62M Buy
+514,500
New +$3.66M 0.03% 575

Gabelli Funds's RPTP Position: Q4 2016 in Review

Gabelli Funds sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 514,500 shares — an estimated $4.62M sold.

Gabelli Funds first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $4.62M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Gabelli Funds reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Gabelli Funds sold 514,500 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $4.62M.
  • Gabelli Funds first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • Gabelli Funds's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $4.62M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Gabelli Funds's 13F filing for Q4 2016, filed 10 Feb 2017.